Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.6579 | 61 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.56507 | 60 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.56794 | 60 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.43313 | 58 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.56191 | 60 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.63189 | 59 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.75256 | 61 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.56385 | 59 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.50612 | 58 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.43704 | 57 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.57972 | 60 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.57745 | 60 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.64728 | 61 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.55709 | 59 |